These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23112857)

  • 1. MeCP2 dependent heterochromatin reorganization during neural differentiation of a novel Mecp2-deficient embryonic stem cell reporter line.
    Bertulat B; De Bonis ML; Della Ragione F; Lehmkuhl A; Milden M; Storm C; Jost KL; Scala S; Hendrich B; D'Esposito M; Cardoso MC
    PLoS One; 2012; 7(10):e47848. PubMed ID: 23112857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATRX Contributes to MeCP2-Mediated Pericentric Heterochromatin Organization during Neural Differentiation.
    Marano D; Fioriniello S; Fiorillo F; Gibbons RJ; D'Esposito M; Della Ragione F
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: new perspective for Rett syndrome.
    Squillaro T; Alessio N; Cipollaro M; Melone MA; Hayek G; Renieri A; Giordano A; Galderisi U
    Mol Biol Cell; 2012 Apr; 23(8):1435-45. PubMed ID: 22357617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons.
    Yazdani M; Deogracias R; Guy J; Poot RA; Bird A; Barde YA
    Stem Cells; 2012 Oct; 30(10):2128-39. PubMed ID: 22865604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.
    Mellios N; Feldman DA; Sheridan SD; Ip JPK; Kwok S; Amoah SK; Rosen B; Rodriguez BA; Crawford B; Swaminathan R; Chou S; Li Y; Ziats M; Ernst C; Jaenisch R; Haggarty SJ; Sur M
    Mol Psychiatry; 2018 Apr; 23(4):1051-1065. PubMed ID: 28439102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
    Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
    Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MeCP2 and Major Satellite Forward RNA Cooperate for Pericentric Heterochromatin Organization.
    Fioriniello S; Csukonyi E; Marano D; Brancaccio A; Madonna M; Zarrillo C; Romano A; Marracino F; Matarazzo MR; D'Esposito M; Della Ragione F
    Stem Cell Reports; 2020 Dec; 15(6):1317-1332. PubMed ID: 33296675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MeCP2 Rett mutations affect large scale chromatin organization.
    Agarwal N; Becker A; Jost KL; Haase S; Thakur BK; Brero A; Hardt T; Kudo S; Leonhardt H; Cardoso MC
    Hum Mol Genet; 2011 Nov; 20(21):4187-95. PubMed ID: 21831886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MeCP2 links heterochromatin condensates and neurodevelopmental disease.
    Li CH; Coffey EL; Dall'Agnese A; Hannett NM; Tang X; Henninger JE; Platt JM; Oksuz O; Zamudio AV; Afeyan LK; Schuijers J; Liu XS; Markoulaki S; Lungjangwa T; LeRoy G; Svoboda DS; Wogram E; Lee TI; Jaenisch R; Young RA
    Nature; 2020 Oct; 586(7829):440-444. PubMed ID: 32698189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
    Peddada S; Yasui DH; LaSalle JM
    Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatio-temporal dynamics and localization of MeCP2 and pathological mutants in living cells.
    Marchi M; Guarda A; Bergo A; Landsberger N; Kilstrup-Nielsen C; Ratto GM; Costa M
    Epigenetics; 2007 Sep; 2(3):187-97. PubMed ID: 17965612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
    Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
    Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLP inhibits heterochromatin clustering and myogenic differentiation by repressing MeCP2.
    Choi MH; Palanichamy Kala M; Ow JR; Rao VK; Suriyamurthy S; Taneja R
    J Mol Cell Biol; 2018 Apr; 10(2):161-174. PubMed ID: 28992061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular pathology of Rett syndrome: synopsis and update.
    Akbarian S; Jiang Y; Laforet G
    Neuromolecular Med; 2006; 8(4):485-94. PubMed ID: 17028371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc finger protein 483 (ZNF483) regulates neuronal differentiation and methyl-CpG-binding protein 2 (MeCP2) intracellular localization.
    Yasui G; Katayama S; Kubota Y; Takatsuka H; Ito M; Inazu T
    Biochem Biophys Res Commun; 2021 Sep; 568():68-75. PubMed ID: 34192606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells.
    Livide G; Patriarchi T; Amenduni M; Amabile S; Yasui D; Calcagno E; Lo Rizzo C; De Falco G; Ulivieri C; Ariani F; Mari F; Mencarelli MA; Hell JW; Renieri A; Meloni I
    Eur J Hum Genet; 2015 Feb; 23(2):195-201. PubMed ID: 24916645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation.
    Singleton MK; Gonzales ML; Leung KN; Yasui DH; Schroeder DI; Dunaway K; LaSalle JM
    Neurobiol Dis; 2011 Jul; 43(1):190-200. PubMed ID: 21420494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted manipulation of heterochromatin rescues MeCP2 Rett mutants and re-establishes higher order chromatin organization.
    Casas-Delucchi CS; Becker A; Bolius JJ; Cardoso MC
    Nucleic Acids Res; 2012 Dec; 40(22):e176. PubMed ID: 22923521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
    Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
    Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-22 regulates smooth muscle cell differentiation from stem cells by targeting methyl CpG-binding protein 2.
    Zhao H; Wen G; Huang Y; Yu X; Chen Q; Afzal TA; Luong le A; Zhu J; Ye S; Zhang L; Xiao Q
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):918-29. PubMed ID: 25722434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.